214194-15-7

Basic information

• Product Name: (4S,5R)-2,2-dimethyl-5-phenyl-[1,3]dioxolane-4-carboxylic acid methyl ester
• Synonyms: (4S,5R)-2,2-dimethyl-5-phenyl-[1,3]dioxolane-4-carboxylic acid methyl ester
• CAS NO: 214194-15-7
• Molecular Weight: 236.268
• Mol File: 214194-15-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: (4S,5R)-2,2-dimethyl-5-phenyl-[1,3]dioxolane-4-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (4S,5R)-2,2-dimethyl-5-phenyl-[1,3]dioxolane-4-carboxylic acid methyl ester(214194-15-7)
• EPA Substance Registry System: (4S,5R)-2,2-dimethyl-5-phenyl-[1,3]dioxolane-4-carboxylic acid methyl ester(214194-15-7)

Safety Data

• Hazardous Substances Data: 214194-15-7(Hazardous Substances Data)

Upstream product

• 140-10-3 (E)-3-phenylacrylic acid 
• 33863-75-1 (±)-cis-phenyloxirane-2-carbonitrile 
• 100-52-7 benzaldehyde 
• 133520-53-3 2,3-Dihydroxy-3-phenylpropannitril 
• 67-56-1 methanol 
• 133520-56-6 2,2-Dimethyl-5-phenyl-1,3-dioxolan-4-carbonitril 
• 103-26-4 methyl cinnamate 
• 103-26-4 Methyl cinnamate 
• 124649-67-8 methyl (2S,3R)-3-phenyl-2,3-dihydroxypropanoate 
• 77-76-9 2,2-dimethoxy-propane 

Downstream Products

• 133520-57-7 (4S,5R)-4-(hydroxymethyl)-2,2-dimethyl-5-phenyl-1,3-dioxolane 
• 910484-78-5 acrylic acid (R)-1-{(4R,5R)-2,2-dimethyl-5-phenyl[1,3]dioxolan-4-yl}-2,2-difluorobut-3-enyl ester 
• 910484-79-6 (S)-6-{(4S,5R)-2,2-dimethyl-5-phenyl[1,3]dioxolan-4-yl}-5,5-difluoro-5,6-dihydropyran-2-one 
• 910484-80-9 (R)-6-{(4S,5R)-2,2-dimethyl-5-phenyl[1,3]dioxolan-4-yl}-5,5-difluoro-5,6-dihydropyran-2-one 
• 910484-74-1 (S)-1-{(4R,5R)-2,2-dimethyl-5-phenyl[1,3]dioxolan-4-yl}-2,2-difluorobut-3-en-1-ol 
• 910484-75-2 (R)-1-{(4R,5R)-2,2-dimethyl-5-phenyl[1,3]dioxolan-4-yl}-2,2-difluorobut-3-en-1-ol 
• 910484-77-4 acrylic acid (S)-1-{(4R,5R)-2,2-dimethyl-5-phenyl[1,3]dioxolan-4-yl}-2,2-difluorobut-3-enyl ester 
• 130796-32-6 (4S,5R)-trans-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-carbaldehyde 
• 124649-67-8 methyl (2S,3R)-3-phenyl-2,3-dihydroxypropanoate 

Relevant articles and documents

SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER

The present invention relates to a pharmaceutical composition for treating and/or alleviating a psychiatric disorder comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a pharmaceutical composition for inducing anti-stress, anti-anxiety and/or anti-depressant activities comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient.

SULFAMATE DERIVATIVE COMPOUND FOR USE IN PREVENTING OR TREATING EPILEPSY

The present invention relates to a pharmaceutical composition for treating or preventing epilepsy containing a sulfamate derivative compound and/or pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a method for treatment or prevention epilepsy comprising administering a sulfamate derivative compound in a pharmaceutically effective amount to a subject in need of treatment or prevention of epilepsy.

Highly diastereoselective total syntheses of (+)-7-epigoniodiol, (-)-8-epigoniodiol, and (+)-9-deoxygoniopypyrone

An expedient concise total synthesis of (+)-7-epigoniodiol, (-)-8-epigoniodiol, and (+)-9-deoxygoniopypyrone is accomplished. The key transformations include a catalytic hydroxylation and base-mediated N-(acetyl)oxazolidinone addition reactions, which cou